Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Agitation and Aggression in Alzheimer's Disease”

17 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 17 of 17 results

Large-scale testing (Phase 3)Study completedNCT00898807
What this trial is testing

Citalopram for Agitation in Alzheimer's Disease

Who this might be right for
Alzheimer's DiseaseAgitation
JHSPH Center for Clinical Trials 186
Testing effectiveness (Phase 2)Ended earlyNCT01766336
What this trial is testing

A 36-Week Safety Extension Study of ELND005 as a Treatment for Agitation and Aggression in Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
OPKO Health, Inc. 296
Testing effectiveness (Phase 2)Study completedNCT01735630
What this trial is testing

Efficacy and Safety Study of ELND005 as a Treatment for Agitation and Aggression in Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
OPKO Health, Inc. 350
Testing effectiveness (Phase 2)Ended earlyNCT03044249
What this trial is testing

MP-101 in Dementia-Related Psychosis and/or Agitation and Aggression

Who this might be right for
PsychosisDementiaAggression+2 more
Mediti Pharma Inc. 81
Early research (Phase 1)Study completedNCT05227118
What this trial is testing

Elpipodect (MK-8189) Safety and Tolerability in Participants With Alzheimer's Disease With or Without Symptoms of Agitation-Aggression and/or Psychosis (MK-8189-017)

Who this might be right for
Alzheimer's Disease
Merck Sharp & Dohme LLC 29
Testing effectiveness (Phase 2)Looking for participantsNCT05543681
What this trial is testing

Clinical Trial on Agitation in Alzheimer's Dementia

Who this might be right for
Alzheimer DiseaseAgitation,PsychomotorCare Giving Burden+2 more
IGC Pharma, LLC 164
Post-approval studies (Phase 4)Study completedNCT00401167
What this trial is testing

Memantine for Agitation and Aggression in Severe Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Sunnybrook Health Sciences Centre 31
Post-approval studies (Phase 4)Study completedNCT00417482
What this trial is testing

Antipsychotic Discontinuation in Alzheimer's Disease

Who this might be right for
Alzheimer DiseasePsychotic DisordersAgitation+1 more
New York State Psychiatric Institute 180
Not applicableUnknownNCT00703430
What this trial is testing

Memantine on Aggression and Agitation of Alzheimer's Disease (AD)

Who this might be right for
Alzheimer's Disease
Peking University 50
Testing effectiveness (Phase 2)Study completedNCT01584440
What this trial is testing

Efficacy, Safety and Tolerability Study of AVP-923 (Dextromethorphan/Quinidine) for Treatment of Symptoms of Agitation in Participants With Alzheimer's Disease

Who this might be right for
AgitationAlzheimer's Disease
Avanir Pharmaceuticals 220
Not applicableActive Not RecruitingNCT03672201
What this trial is testing

Standardizing Care for Neuropsychiatric Symptoms and Quality of Life in Dementia

Who this might be right for
Alzheimer's DiseaseAlzheimer Dementia (AD)Aggression
Centre for Addiction and Mental Health 187
Testing effectiveness (Phase 2)Study completedNCT00843518
What this trial is testing

Treatment for Aggression and Agitation in Patients With Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Eli Lilly and Company 132
Testing effectiveness (Phase 2)Looking for participantsNCT04436081
What this trial is testing

Effects of THC-Free CBD Oil on Agitation in Patients With Alzheimer's Disease

Who this might be right for
Alzheimer DiseaseDementiaMajor Neurocognitive Disorder With Aggressive Behavior
Eastern Virginia Medical School 40
Testing effectiveness (Phase 2)Study completedNCT02129348
What this trial is testing

Treatment of Psychosis and Agitation in Alzheimer's Disease

Who this might be right for
Alzheimer's DiseasePsychosisAgitation
New York State Psychiatric Institute 77
Testing effectiveness (Phase 2)Ended earlyNCT02992132
What this trial is testing

Study to Examine the Safety and Efficacy of Pimavanserin for the Treatment of Agitation and Aggression in Alzheimer's Disease (SERENE)

Who this might be right for
Agitation and Aggression in Alzheimer's Disease
ACADIA Pharmaceuticals Inc. 111
Testing effectiveness (Phase 2)Looking for participantsNCT06781333
What this trial is testing

Human Mesenchymal Stem Cells (hMSC) in Behavioral Problems Due to Alzheimer's Disease.

Who this might be right for
Alzheimer DiseaseAgitation in Dementia
Bernard (Barry) Baumel 8
Testing effectiveness (Phase 2)Study completedNCT03118947
What this trial is testing

Pimavanserin for the Treatment of Agitation and Aggression in Subjects With Alzheimer's Disease

Who this might be right for
Agitation and Aggression in Alzheimer's Disease
ACADIA Pharmaceuticals Inc. 79